| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0306-4522(02)00204-X |
| P698 | PubMed publication ID | 12150782 |
| P50 | author | Edwin Hillel Kolodny | Q115923107 |
| Thomas Wisniewski | Q41043812 | ||
| P2093 | author name string | Wang ZH | |
| Ji Y | |||
| Raksadawan N | |||
| Pastores GM | |||
| Zeng B | |||
| Shan W | |||
| P2860 | cites work | Brain-derived neurotrophic factor suppresses programmed death of cerebellar granule cells through a posttranslational mechanism | Q73313633 |
| Transplantation of embryonic dopamine neurons for severe Parkinson's disease | Q29617304 | ||
| A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease. | Q32016206 | ||
| Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease | Q33951094 | ||
| Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease | Q34065279 | ||
| Possible extrapyramidal system degradation in Parkinson's disease | Q34117395 | ||
| Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression | Q34467878 | ||
| Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. | Q35374311 | ||
| Brain-derived neurotrophic factor-transduced fibroblasts: production of BDNF and effects of grafting to the adult rat brain. | Q37260489 | ||
| The causes of Parkinson's disease are being unraveled and rational neuroprotective therapy is close to reality | Q40842068 | ||
| Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease | Q40846012 | ||
| Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease | Q40861090 | ||
| The use of nonneuronal cells for gene delivery | Q40911146 | ||
| Overexpression of HA-Bax but not Bcl-2 or Bcl-XL attenuates 6-hydroxydopamine-induced neuronal apoptosis | Q40984104 | ||
| Correlation of glioma cell regression with inhibition of insulin-like growth factor 1 and insulin-like growth factor-binding protein-2 expression | Q41088988 | ||
| An Acid-Treatment Method for the Enhanced Detection of GDNF in Biological Samples | Q41107033 | ||
| Dopaminergic neurons protected from degeneration by GDNF gene therapy | Q41128316 | ||
| GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine. | Q41143148 | ||
| Tetrahydrobiopterin-dependent functional recovery in 6-hydroxydopamine-treated rats by intracerebral grafting of fibroblasts transfected with tyrosine hydroxylase cDNA | Q41649774 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Neurotrophins protect cultured cerebellar granule neurons against the early phase of cell death by a two-component mechanism | Q42438471 | ||
| Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase | Q43185222 | ||
| Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer | Q44694208 | ||
| Toward autologous ex vivo gene therapy for the central nervous system with human adult astrocytes | Q45856349 | ||
| Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease | Q45869225 | ||
| Gene therapy of Parkinson disease model rat by direct injection of plasmid DNA-lipofectin complex | Q45876100 | ||
| Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease | Q45876215 | ||
| Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease. | Q45876510 | ||
| Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice | Q45889665 | ||
| In vivo and in vitro glioma cell killing induced by an adenovirus expressing both cytosine deaminase and thymidine kinase and its association with interferon-alpha | Q48136963 | ||
| Brain-derived neurotrophic factor mediates the anti-apoptotic effect of NMDA in cerebellar granule neurons: signal transduction cascades and site of ethanol action. | Q48231010 | ||
| Dopaminergic neurons degenerate by apoptosis in Parkinson's disease. | Q48255275 | ||
| Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system | Q48459449 | ||
| Insulin receptor substrate (IRS)-1 and IRS-2 are tyrosine-phosphorylated and associated with phosphatidylinositol 3-kinase in response to brain-derived neurotrophic factor in cultured cerebral cortical neurons | Q48578988 | ||
| Abnormal cerebellar development and foliation in BDNF-/- mice reveals a role for neurotrophins in CNS patterning | Q48644054 | ||
| Prevention of apoptotic motoneuron death in vitro by neurotrophins and muscle extract | Q48654234 | ||
| Brain derived neurotrophic factor induces a rapid upregulation of synaptophysin and tau proteins via the neurotrophin receptor TrkB in rat cerebellar granule cells. | Q48705309 | ||
| Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra. | Q48765090 | ||
| Signaling pathways and survival effects of BDNF and NT-3 on cultured cerebellar granule cells | Q48859167 | ||
| Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression. | Q49137803 | ||
| Tetrahydrobiopterin in Striatum: Localization in Dopamine Nerve Terminals and Role in Catecholamine Synthesis | Q49156811 | ||
| Gene therapy for Parkinson's disease | Q60360924 | ||
| Histochemical detection of apoptosis in Parkinson's disease. | Q67401850 | ||
| 6-Hydroxydopamine Lesion of the Rat Substantia Nigra: Time Course and Morphology of Cell Death | Q71799443 | ||
| Decarboxylation of L-dopa by cultured mouse astrocytes | Q72707627 | ||
| Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion | Q73131503 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | astrocyte | Q502961 |
| P304 | page(s) | 629-640 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Neuroscience | Q15708571 |
| P1476 | title | Therapeutic effects of astrocytes expressing both tyrosine hydroxylase and brain-derived neurotrophic factor on a rat model of Parkinson's disease | |
| P478 | volume | 113 |
| Q48769891 | BDNF promotes human neural stem cell growth via GSK-3β-mediated crosstalk with the wnt/β-catenin signaling pathway |
| Q34358267 | Bone marrow-derived mesenchymal stem cells increase dopamine synthesis in the injured striatum |
| Q44195362 | Brain-derived neurotrophic factor stimulates proliferation and differentiation of neural stem cells, possibly by triggering the Wnt/β-catenin signaling pathway |
| Q30394681 | Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine |
| Q34473733 | Pgc-1α overexpression downregulates Pitx3 and increases susceptibility to MPTP toxicity associated with decreased Bdnf |
| Q26827281 | Potential therapeutic effects of neurotrophins for acute and chronic neurological diseases |
| Q38645464 | Real Time Imaging of Biomarkers in the Parkinson's Brain Using Mini-Implantable Biosensors. II. Pharmaceutical Therapy with Bromocriptine |
| Q48867401 | Task-related variations in the surface EMG of the human first dorsal interosseous muscle |
| Q44343767 | The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats |
| Q39668035 | The effect of lentivirus-mediated TH and GDNF genetic engineering mesenchymal stem cells on Parkinson's disease rat model |
| Q51591930 | The effect of stimulated microglia conditioned media on BDNF gene expression of striatal astrocytes: quantification by real-time PCR. |
| Q45042264 | Transplanted bone marrow stromal cells migrate, differentiate and improve motor function in rats with experimentally induced cerebral stroke. |
| Q35599603 | Use of gene therapy in central nervous system repair |
Search more.